Page last updated: 2024-12-05

4-methylcatechol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Occurs in Manufacturing Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

4-Methylcatechol, also known as 4-hydroxy-3-methylphenol, is a naturally occurring phenolic compound found in various plants. It exhibits antioxidant properties and has been studied for its potential applications in various fields. Its synthesis can be achieved through various methods, including the methylation of catechol or the oxidation of 4-methylguaiacol. 4-Methylcatechol is known for its ability to scavenge free radicals and protect against oxidative stress. It has also shown antimicrobial activity against certain bacteria and fungi. Furthermore, it has been investigated for its potential role in plant defense mechanisms and its impact on human health. Due to its biological activities and potential applications, 4-methylcatechol remains an interesting subject of research.'

FloraRankFlora DefinitionFamilyFamily Definition
PiceagenusA plant genus in the family PINACEAE, order Pinales, class Pinopsida, division Coniferophyta. They are evergreen, pyramidal trees with whorled branches and thin, scaly bark. Each of the linear, spirally arranged leaves are joined near the stem on a separate woody base.[MeSH]PinaceaeA plant family of the order Pinales, class Pinopsida, division Tracheophyta, known for the various conifers.[MeSH]

Cross-References

ID SourceID
PubMed CID9958
CHEMBL ID158766
CHEBI ID17254
SCHEMBL ID12388
MeSH IDM0070296

Synonyms (83)

Synonym
smr000471857
MLS001066329
AC-12438
5-methylcatechol
MCT ,
2-hydroxy-4-methylphenol
p-methylcatechol
CHEBI:17254 ,
C0126
nsc-17489
toluene-3,4-diol
4-methylpyrocatechol
4-methyl-1,2-dihydroxybenzene
nsc17489
pyrocatechol, 4-methyl-
p-methylpyrocatechol
homocatechol
homopyrocatechol
4-methylbenzene-1,2-diol
inchi=1/c7h8o2/c1-5-2-3-6(8)7(9)4-5/h2-4,8-9h,1h
1,2-benzenediol, 4-methyl-
einecs 207-214-5
ccris 3333
nsc 17489
brn 0636512
4-methylcatechol ,
452-86-8
C06730
1,2-dihydroxy-4-methylbenzene
3,4-dihydroxytoluene
4-methyl-1,2-benzenediol
4-methylcatechol, >=95%
DB04120
BMSE000475
CHEMBL158766 ,
M0413
AKOS000121479
NCGC00248773-01
tox21_200632
NCGC00258186-01
cas-452-86-8
dtxsid5020861 ,
dtxcid30861
unii-12gli7jgb3
12gli7jgb3 ,
FT-0618974
EPITOPE ID:150928
methyl catechol, 4-
hmdb00873
droxidopa metabolite (3,4-dihydroxytoluene)
1-methyl-3,4-dihydroxybenzene
S5616
SCHEMBL12388
4-methyl pyrocatechol
4-methyl-catechol
1,2-dihydroxy-5-methylbenzene
4-methyl catechol
4-methyl-1,2-dihydroxy benzene
1,1-ferrocenedimethanol
W-106144
4-methylbenzene-1,2-diol #
4K7N
mfcd00002205
F0001-1227
D70562
4-methyl-d3-catechol
4-methyl-pyrocatechol
4-metylcatechol
4-methylcatehol
HY-W012814
A872403
AS-11944
CS-W013530
Q15303189
AMY25678
HMS3886M12
SY012747
CCG-266087
1219803-18-5
4-methyl-benzene-1,2-diol
bdbm50548723
EN300-21094
Z104490128

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" This is supported by the detection of such adverse effects in plate assays using Escherichia coli tester strains deficient in the OxyR function, but not in OxyR(+) strains."( Nitric oxide promotes strong cytotoxicity of phenolic compounds against Escherichia coli: the influence of antioxidant defenses.
Blanco, M; Escudero, JC; González, MC; Herrera, G; López-Gresa, MP; Martínez, A; O'Connor, JE; Primo, J; Urios, A, 2003
)
0.32

Bioavailability

ExcerptReferenceRelevance
" Its bioavailability is, however, low and, therefore, its metabolites could rather be responsible for this effect."( A Mixture of Phenolic Metabolites of Quercetin Can Decrease Elevated Blood Pressure of Spontaneously Hypertensive Rats Even in Low Doses.
Mladěnka, P; Najmanová, I; Pourová, J, 2020
)
0.56
" However, dietary polyphenols generally have low bioavailability and reach low plasma concentrations."( The Antiplatelet Effect of 4-Methylcatechol in a Real Population Sample and Determination of the Mechanism of Action.
Blaha, V; Carazo, A; Hrubša, M; Javorská, L; Karlíčková, J; Konečný, L; Krčmová, LK; Matoušová, K; Mladěnka, P; Musil, F; Paclíková, M; Parvin, MS; Skořepa, P; Šmahelová, A, 2022
)
1.02

Dosage Studied

ExcerptRelevanceReference
" 4-MC elevated BDNF content in culture media of both rat astrocytes and neurons with different dose-response relations."( 4-methylcatechol increases brain-derived neurotrophic factor content and mRNA expression in cultured brain cells and in rat brain in vivo.
Fukumitsu, H; Furukawa, S; Furukawa, Y; Ito, H; Ito, M; Nitta, A; Nomoto, H; Ohmiya, M; Sometani, A, 1999
)
1.75
" The fact that the half-life of IL-6 is only approximately 5 h while weekly dosing was neuroprotective strongly suggests activation by IL-6 of effector molecule(s) with longer duration of action."( Interleukin-6 attenuates the development of experimental diabetes-related neuropathy.
Andriambeloson, E; Baillet, C; Callizot, N; Dreano, M; Garotta, G; Vitte, PA, 2006
)
0.33
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Occurs in Manufacturing (32 Product(s))

Product Categories

Product CategoryProducts
Beauty & Personal Care21
Active Lifestyle & Fitness1
Vitamins & Supplements10

Products

ProductBrandCategoryCompounds Matched from IngredientsDate Retrieved
Humble Brands Deodorant Plastic Free Rosemary & Mint -- 2.65 ozHumble BrandsBeauty & Personal CareMCT, MCT, sodium bicarbonate2024-11-29 10:47:42
Humble Brands Deodorant Plastic Free Bergamot & Ginger -- 2.65 ozHumble BrandsBeauty & Personal CareMCT, citral, citronellol, MCT, linalool, sodium bicarbonate2024-11-29 10:47:42
Humble Brands Deodorant Plastic Free Moroccan Rose -- 2.65 ozHumble BrandsBeauty & Personal Caregeranium, MCT, citronellol, geraniol, MCT, sodium bicarbonate2024-11-29 10:47:42
Humble Brands Deodorant Plastic Free Palo Santo & Frankincense -- 2.65 ozHumble BrandsBeauty & Personal CareMCT, MCT, sodium bicarbonate2024-11-29 10:47:42
Humble Brands Deodorant Plastic Free Patchouli & Copal -- 2.65 ozHumble BrandsBeauty & Personal CareMCT, MCT, linalool, sodium bicarbonate2024-11-29 10:47:42
Humble Brands Deodorant Plastic Free Vegan & Sensitive Skin Simply Unscented -- 2.65 ozHumble BrandsBeauty & Personal CareMCT, MCT2024-11-29 10:47:42
Humble Brands Deodorant Plastic Free Vegan & Sensitive Skin Mountain Lavender -- 2.65 ozHumble BrandsBeauty & Personal CareMCT, MCT2024-11-29 10:47:42
Humble Brands Deodorant Vegan & Sensitive Skin Formula Bergamot & Ginger -- 2.5 ozHumble BrandsBeauty & Personal CareMCT, citral, geraniol, MCT, linalool2024-11-29 10:47:42
Humble Brands Deodorant Vegan & Sensitive Skin Formula Moroccan Rose -- 2.5 ozHumble BrandsBeauty & Personal Caregeranium, MCT, citronellol, geraniol, MCT2024-11-29 10:47:42
Humble Brands Deodorant Vegan & Sensitive Skin Formula Palo Santo & Frankincense -- 2.5 ozHumble BrandsBeauty & Personal CareMCT, MCT2024-11-29 10:47:42
Humble Brands Deodorant Vegan & Sensitive Skin Formula Patchouli & Copal -- 2.5 ozHumble BrandsBeauty & Personal CareMCT, MCT, linalool2024-11-29 10:47:42
Humble Brands Deodorant Vegan & Sensitive Skin Formula Vanilla & Cardamon -- 2.5 ozHumble BrandsBeauty & Personal CareMCT, MCT2024-11-29 10:47:42
Irwin Naturals Brain Awake Max3™ + Nitric Oxide Booster -- 60 Liquid SoftgelsIrwin NaturalsActive Lifestyle & FitnessMCT, Acetyl L-Carnitine, annatto, glycerin, MCT, maltodextrin, mannitol, Vitamin B6, titanium dioxide, Vitamin B12, Vitamin B62024-11-29 10:47:42
Irwin Naturals Prosta-Strong RED™ -- 80 Liquid SoftgelsIrwin NaturalsVitamins & SupplementsMCT, annatto, glycerin, MCT2024-11-29 10:47:42
Sunwarrior Enzorb Digestive Enzymes -- 90 Vegan CapsulesSunwarriorVitamins & Supplements MCT, Cellulase, MCT2024-11-29 10:47:42
Twinlab L-Arginine -- 500 mg - 100 CapsulesTwinlabVitamins & SupplementsMCT, cellulose, MCT2024-11-29 10:47:42
Twinlab Potassium Caps -- 180 CapsulesTwinlabVitamins & SupplementsMCT, MCT2024-11-29 10:47:42
Zatik Gratitude Face Serum -- 1 fl ozZatikBeauty & Personal CareMCT, MCT2024-11-29 10:47:42
Zatik Hair Serum Argan & Black Seed -- 2 fl ozZatikBeauty & Personal Careorange, MCT, MCT2024-11-29 10:47:42
Zatik Nutri Face Serum -- 1 fl ozZatikBeauty & Personal CareMCT, chamomile, MCT2024-11-29 10:47:42
Zatik Odor Defense Roll-On Deodorant Lavender & Moringa -- 3 fl ozZatikBeauty & Personal CareMCT, hydroxyethyl cellulose, calcium carbonate2024-11-29 10:47:42
Zatik Odor Defense Roll-On Deodorant Unscented -- 3 fl ozZatikBeauty & Personal CareMCT, gluconodeltalactone, hydroxyethyl cellulose, calcium carbonate2024-11-29 10:47:42
Zatik Relieve Eye Serum -- 1 fl ozZatikBeauty & Personal CareMCT, chamomile, MCT2024-11-29 10:47:42
Zatik Softening & Hydrating Conditioner Maca & Jojoba -- 10.8 fl ozZatikBeauty & Personal Careorange, MCT, glucono delta lactone, cetearyl alcohol, tocopherol, decyl glucoside, tocopherol, MCT, vitamin B52024-11-29 10:47:42
Zatik Softening & Hydrating Shampoo Maca & Jojoba -- 10.8 fl ozZatikBeauty & Personal Careorange, MCT, glucono delta lactone, tocopherol, decyl glucoside, dl-panthenol, tocopherol, hydroxyethyl cellulose, MCT, vitamin B52024-11-29 10:47:42
Zatik Solar Mineral Sunscreen SPF 30 -- 1.7 fl ozZatikBeauty & Personal CareMCT, L-ascorbyl palmitate, tocopherol, tocopherol, hydroxyethyl cellulose, MCT2024-11-29 10:47:42
Zenwise Daily Digestive Enzymes Plus Fast-Acting Probiotics -- 100 Vegetable CapsulesZenwiseVitamins & SupplementsMCT, Microcrystalline cellulose, MCT2024-11-29 10:47:42
Zenwise Digestive Enzymes Plus Fast-Acting Probiotics -- 180 Vegetable CapsulesZenwiseVitamins & SupplementsMCT, MCT2024-11-29 10:47:42
Zenwise Digestive Enzymes Plus Fast-Acting Probiotics -- 60 CapsulesZenwiseVitamins & SupplementsMCT, microcrystalline cellulose, MCT2024-11-29 10:47:42
Zenwise No Bloat -- 100 Vegetable CapsulesZenwiseVitamins & SupplementsMCT, Microcrystalline cellulose, MCT2024-11-29 10:47:42
Zenwise No Bloat -- 160 Vegetable CapsulesZenwiseVitamins & SupplementsMCT, Microcrystalline cellulose, MCT2024-11-29 10:47:42
Zenwise No Bloat -- 60 Vegetable CapsulesZenwiseVitamins & SupplementsMCT, Microcrystalline cellulose, MCT2024-11-29 10:47:42

Roles (5)

RoleDescription
haptenAny substance capable of eliciting an immune response only when attached to a large carrier such as a protein. Examples include dinitrophenols; oligosaccharides; peptides; and heavy metals.
carcinogenic agentA role played by a chemical compound which is known to induce a process of carcinogenesis by corrupting normal cellular pathways, leading to the acquistion of tumoral capabilities.
antioxidantA substance that opposes oxidation or inhibits reactions brought about by dioxygen or peroxides.
human metaboliteAny mammalian metabolite produced during a metabolic reaction in humans (Homo sapiens).
plant metaboliteAny eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
methylcatecholAny member of the class of catechols carrying one or more methyl substituents.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (10)

PathwayProteinsCompounds
Thiazole Biosynthesis I314
methylsalicylate degradation19
naphthalene degradation (aerobic)929
4-methylcatechol degradation (ortho cleavage)415
superpathway of aromatic compound degradation via 2-hydroxypentadienoate5095
naphthalene degradation to acetyl-CoA1138
toluene degradation to 2-hydroxypentadienoate (via 4-methylcatechol)711
toluene degradation II (aerobic) (via 4-methylcatechol)716
superpathway of aerobic toluene degradation3847
4-toluenesulfonate degradation II06

Protein Targets (28)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
LuciferasePhotinus pyralis (common eastern firefly)Potency86.88570.007215.758889.3584AID1224835
acetylcholinesteraseHomo sapiens (human)Potency34.58980.002541.796015,848.9004AID1347398
RAR-related orphan receptor gammaMus musculus (house mouse)Potency48.78660.006038.004119,952.5996AID1159521; AID1159523
GLI family zinc finger 3Homo sapiens (human)Potency12.74570.000714.592883.7951AID1259368; AID1259369; AID1259392
AR proteinHomo sapiens (human)Potency31.17640.000221.22318,912.5098AID1259247; AID743042; AID743063
estrogen receptor 2 (ER beta)Homo sapiens (human)Potency23.64520.000657.913322,387.1992AID1259378
nuclear receptor subfamily 1, group I, member 3Homo sapiens (human)Potency35.70280.001022.650876.6163AID1224838; AID1224839; AID1224893
progesterone receptorHomo sapiens (human)Potency42.04780.000417.946075.1148AID1346795
glucocorticoid receptor [Homo sapiens]Homo sapiens (human)Potency56.66350.000214.376460.0339AID720691; AID720692
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency66.93600.003041.611522,387.1992AID1159552; AID1159553; AID1159555
retinoid X nuclear receptor alphaHomo sapiens (human)Potency20.07170.000817.505159.3239AID1159531
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency11.49290.001530.607315,848.9004AID1224841; AID1224842; AID1224849; AID1259401
farnesoid X nuclear receptorHomo sapiens (human)Potency42.42130.375827.485161.6524AID743217
pregnane X nuclear receptorHomo sapiens (human)Potency59.39410.005428.02631,258.9301AID1346982
estrogen nuclear receptor alphaHomo sapiens (human)Potency28.41630.000229.305416,493.5996AID1259244; AID1259248; AID743069; AID743075; AID743077; AID743078
vitamin D (1,25- dihydroxyvitamin D3) receptorHomo sapiens (human)Potency50.41780.023723.228263.5986AID743241
aryl hydrocarbon receptorHomo sapiens (human)Potency29.20710.000723.06741,258.9301AID743085; AID743122
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_aHomo sapiens (human)Potency66.64120.001723.839378.1014AID743083
thyroid stimulating hormone receptorHomo sapiens (human)Potency59.78810.001628.015177.1139AID1224895; AID1259385
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_aHomo sapiens (human)Potency59.921719.739145.978464.9432AID1159509
Histone H2A.xCricetulus griseus (Chinese hamster)Potency43.28600.039147.5451146.8240AID1224845; AID1224896
thyroid hormone receptor beta isoform 2Rattus norvegicus (Norway rat)Potency25.08780.000323.4451159.6830AID743065; AID743067
heat shock protein beta-1Homo sapiens (human)Potency26.76600.042027.378961.6448AID743210
nuclear factor erythroid 2-related factor 2 isoform 1Homo sapiens (human)Potency14.35740.000627.21521,122.0200AID743219
Voltage-dependent calcium channel gamma-2 subunitMus musculus (house mouse)Potency14.91910.001557.789015,848.9004AID1259244
Cellular tumor antigen p53Homo sapiens (human)Potency59.39410.002319.595674.0614AID651631
Glutamate receptor 2Rattus norvegicus (Norway rat)Potency14.91910.001551.739315,848.9004AID1259244
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Transient receptor potential cation channel subfamily A member 1Homo sapiens (human)EC50 (µMol)11.70000.00033.166210.0000AID1682372
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (141)

Processvia Protein(s)Taxonomy
monoatomic ion transportTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
intracellular calcium ion homeostasisTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
cell surface receptor signaling pathwayTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
response to coldTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
response to xenobiotic stimulusTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
response to organic substanceTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
response to organic cyclic compoundTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
sensory perception of painTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
calcium-mediated signalingTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
response to painTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
thermoceptionTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
detection of mechanical stimulus involved in sensory perception of painTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
detection of chemical stimulus involved in sensory perception of painTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
protein homotetramerizationTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
cellular response to hydrogen peroxideTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
calcium ion transmembrane transportTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
cellular response to organic substanceTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
negative regulation of cell population proliferationCellular tumor antigen p53Homo sapiens (human)
regulation of cell cycleCellular tumor antigen p53Homo sapiens (human)
regulation of cell cycle G2/M phase transitionCellular tumor antigen p53Homo sapiens (human)
DNA damage responseCellular tumor antigen p53Homo sapiens (human)
ER overload responseCellular tumor antigen p53Homo sapiens (human)
cellular response to glucose starvationCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
regulation of apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
positive regulation of miRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
negative regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
mitophagyCellular tumor antigen p53Homo sapiens (human)
in utero embryonic developmentCellular tumor antigen p53Homo sapiens (human)
somitogenesisCellular tumor antigen p53Homo sapiens (human)
release of cytochrome c from mitochondriaCellular tumor antigen p53Homo sapiens (human)
hematopoietic progenitor cell differentiationCellular tumor antigen p53Homo sapiens (human)
T cell proliferation involved in immune responseCellular tumor antigen p53Homo sapiens (human)
B cell lineage commitmentCellular tumor antigen p53Homo sapiens (human)
T cell lineage commitmentCellular tumor antigen p53Homo sapiens (human)
response to ischemiaCellular tumor antigen p53Homo sapiens (human)
nucleotide-excision repairCellular tumor antigen p53Homo sapiens (human)
double-strand break repairCellular tumor antigen p53Homo sapiens (human)
regulation of DNA-templated transcriptionCellular tumor antigen p53Homo sapiens (human)
regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
protein import into nucleusCellular tumor antigen p53Homo sapiens (human)
autophagyCellular tumor antigen p53Homo sapiens (human)
DNA damage responseCellular tumor antigen p53Homo sapiens (human)
DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrestCellular tumor antigen p53Homo sapiens (human)
DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediatorCellular tumor antigen p53Homo sapiens (human)
transforming growth factor beta receptor signaling pathwayCellular tumor antigen p53Homo sapiens (human)
Ras protein signal transductionCellular tumor antigen p53Homo sapiens (human)
gastrulationCellular tumor antigen p53Homo sapiens (human)
neuroblast proliferationCellular tumor antigen p53Homo sapiens (human)
negative regulation of neuroblast proliferationCellular tumor antigen p53Homo sapiens (human)
protein localizationCellular tumor antigen p53Homo sapiens (human)
negative regulation of DNA replicationCellular tumor antigen p53Homo sapiens (human)
negative regulation of cell population proliferationCellular tumor antigen p53Homo sapiens (human)
determination of adult lifespanCellular tumor antigen p53Homo sapiens (human)
mRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
rRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
response to salt stressCellular tumor antigen p53Homo sapiens (human)
response to inorganic substanceCellular tumor antigen p53Homo sapiens (human)
response to X-rayCellular tumor antigen p53Homo sapiens (human)
response to gamma radiationCellular tumor antigen p53Homo sapiens (human)
positive regulation of gene expressionCellular tumor antigen p53Homo sapiens (human)
cardiac muscle cell apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of cardiac muscle cell apoptotic processCellular tumor antigen p53Homo sapiens (human)
glial cell proliferationCellular tumor antigen p53Homo sapiens (human)
viral processCellular tumor antigen p53Homo sapiens (human)
glucose catabolic process to lactate via pyruvateCellular tumor antigen p53Homo sapiens (human)
cerebellum developmentCellular tumor antigen p53Homo sapiens (human)
negative regulation of cell growthCellular tumor antigen p53Homo sapiens (human)
DNA damage response, signal transduction by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
negative regulation of transforming growth factor beta receptor signaling pathwayCellular tumor antigen p53Homo sapiens (human)
mitotic G1 DNA damage checkpoint signalingCellular tumor antigen p53Homo sapiens (human)
negative regulation of telomere maintenance via telomeraseCellular tumor antigen p53Homo sapiens (human)
T cell differentiation in thymusCellular tumor antigen p53Homo sapiens (human)
tumor necrosis factor-mediated signaling pathwayCellular tumor antigen p53Homo sapiens (human)
regulation of tissue remodelingCellular tumor antigen p53Homo sapiens (human)
cellular response to UVCellular tumor antigen p53Homo sapiens (human)
multicellular organism growthCellular tumor antigen p53Homo sapiens (human)
positive regulation of mitochondrial membrane permeabilityCellular tumor antigen p53Homo sapiens (human)
cellular response to glucose starvationCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
positive regulation of apoptotic processCellular tumor antigen p53Homo sapiens (human)
negative regulation of apoptotic processCellular tumor antigen p53Homo sapiens (human)
entrainment of circadian clock by photoperiodCellular tumor antigen p53Homo sapiens (human)
mitochondrial DNA repairCellular tumor antigen p53Homo sapiens (human)
regulation of DNA damage response, signal transduction by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
positive regulation of neuron apoptotic processCellular tumor antigen p53Homo sapiens (human)
transcription initiation-coupled chromatin remodelingCellular tumor antigen p53Homo sapiens (human)
negative regulation of proteolysisCellular tumor antigen p53Homo sapiens (human)
negative regulation of DNA-templated transcriptionCellular tumor antigen p53Homo sapiens (human)
positive regulation of DNA-templated transcriptionCellular tumor antigen p53Homo sapiens (human)
positive regulation of RNA polymerase II transcription preinitiation complex assemblyCellular tumor antigen p53Homo sapiens (human)
positive regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
response to antibioticCellular tumor antigen p53Homo sapiens (human)
fibroblast proliferationCellular tumor antigen p53Homo sapiens (human)
negative regulation of fibroblast proliferationCellular tumor antigen p53Homo sapiens (human)
circadian behaviorCellular tumor antigen p53Homo sapiens (human)
bone marrow developmentCellular tumor antigen p53Homo sapiens (human)
embryonic organ developmentCellular tumor antigen p53Homo sapiens (human)
positive regulation of peptidyl-tyrosine phosphorylationCellular tumor antigen p53Homo sapiens (human)
protein stabilizationCellular tumor antigen p53Homo sapiens (human)
negative regulation of helicase activityCellular tumor antigen p53Homo sapiens (human)
protein tetramerizationCellular tumor antigen p53Homo sapiens (human)
chromosome organizationCellular tumor antigen p53Homo sapiens (human)
neuron apoptotic processCellular tumor antigen p53Homo sapiens (human)
regulation of cell cycleCellular tumor antigen p53Homo sapiens (human)
hematopoietic stem cell differentiationCellular tumor antigen p53Homo sapiens (human)
negative regulation of glial cell proliferationCellular tumor antigen p53Homo sapiens (human)
type II interferon-mediated signaling pathwayCellular tumor antigen p53Homo sapiens (human)
cardiac septum morphogenesisCellular tumor antigen p53Homo sapiens (human)
positive regulation of programmed necrotic cell deathCellular tumor antigen p53Homo sapiens (human)
protein-containing complex assemblyCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stressCellular tumor antigen p53Homo sapiens (human)
thymocyte apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of thymocyte apoptotic processCellular tumor antigen p53Homo sapiens (human)
necroptotic processCellular tumor antigen p53Homo sapiens (human)
cellular response to hypoxiaCellular tumor antigen p53Homo sapiens (human)
cellular response to xenobiotic stimulusCellular tumor antigen p53Homo sapiens (human)
cellular response to ionizing radiationCellular tumor antigen p53Homo sapiens (human)
cellular response to gamma radiationCellular tumor antigen p53Homo sapiens (human)
cellular response to UV-CCellular tumor antigen p53Homo sapiens (human)
stem cell proliferationCellular tumor antigen p53Homo sapiens (human)
signal transduction by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
reactive oxygen species metabolic processCellular tumor antigen p53Homo sapiens (human)
cellular response to actinomycin DCellular tumor antigen p53Homo sapiens (human)
positive regulation of release of cytochrome c from mitochondriaCellular tumor antigen p53Homo sapiens (human)
cellular senescenceCellular tumor antigen p53Homo sapiens (human)
replicative senescenceCellular tumor antigen p53Homo sapiens (human)
oxidative stress-induced premature senescenceCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathwayCellular tumor antigen p53Homo sapiens (human)
oligodendrocyte apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of execution phase of apoptosisCellular tumor antigen p53Homo sapiens (human)
negative regulation of mitophagyCellular tumor antigen p53Homo sapiens (human)
regulation of mitochondrial membrane permeability involved in apoptotic processCellular tumor antigen p53Homo sapiens (human)
regulation of intrinsic apoptotic signaling pathway by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
positive regulation of miRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
negative regulation of G1 to G0 transitionCellular tumor antigen p53Homo sapiens (human)
negative regulation of miRNA processingCellular tumor antigen p53Homo sapiens (human)
negative regulation of glucose catabolic process to lactate via pyruvateCellular tumor antigen p53Homo sapiens (human)
negative regulation of pentose-phosphate shuntCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to hypoxiaCellular tumor antigen p53Homo sapiens (human)
regulation of fibroblast apoptotic processCellular tumor antigen p53Homo sapiens (human)
negative regulation of reactive oxygen species metabolic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of reactive oxygen species metabolic processCellular tumor antigen p53Homo sapiens (human)
negative regulation of stem cell proliferationCellular tumor antigen p53Homo sapiens (human)
positive regulation of cellular senescenceCellular tumor antigen p53Homo sapiens (human)
positive regulation of intrinsic apoptotic signaling pathwayCellular tumor antigen p53Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (38)

Processvia Protein(s)Taxonomy
calcium channel activityTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
channel activityTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
intracellularly gated calcium channel activityTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
identical protein bindingTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
temperature-gated cation channel activityTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
transcription cis-regulatory region bindingCellular tumor antigen p53Homo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription factor activity, RNA polymerase II-specificCellular tumor antigen p53Homo sapiens (human)
cis-regulatory region sequence-specific DNA bindingCellular tumor antigen p53Homo sapiens (human)
core promoter sequence-specific DNA bindingCellular tumor antigen p53Homo sapiens (human)
TFIID-class transcription factor complex bindingCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription repressor activity, RNA polymerase II-specificCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription activator activity, RNA polymerase II-specificCellular tumor antigen p53Homo sapiens (human)
protease bindingCellular tumor antigen p53Homo sapiens (human)
p53 bindingCellular tumor antigen p53Homo sapiens (human)
DNA bindingCellular tumor antigen p53Homo sapiens (human)
chromatin bindingCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription factor activityCellular tumor antigen p53Homo sapiens (human)
mRNA 3'-UTR bindingCellular tumor antigen p53Homo sapiens (human)
copper ion bindingCellular tumor antigen p53Homo sapiens (human)
protein bindingCellular tumor antigen p53Homo sapiens (human)
zinc ion bindingCellular tumor antigen p53Homo sapiens (human)
enzyme bindingCellular tumor antigen p53Homo sapiens (human)
receptor tyrosine kinase bindingCellular tumor antigen p53Homo sapiens (human)
ubiquitin protein ligase bindingCellular tumor antigen p53Homo sapiens (human)
histone deacetylase regulator activityCellular tumor antigen p53Homo sapiens (human)
ATP-dependent DNA/DNA annealing activityCellular tumor antigen p53Homo sapiens (human)
identical protein bindingCellular tumor antigen p53Homo sapiens (human)
histone deacetylase bindingCellular tumor antigen p53Homo sapiens (human)
protein heterodimerization activityCellular tumor antigen p53Homo sapiens (human)
protein-folding chaperone bindingCellular tumor antigen p53Homo sapiens (human)
protein phosphatase 2A bindingCellular tumor antigen p53Homo sapiens (human)
RNA polymerase II-specific DNA-binding transcription factor bindingCellular tumor antigen p53Homo sapiens (human)
14-3-3 protein bindingCellular tumor antigen p53Homo sapiens (human)
MDM2/MDM4 family protein bindingCellular tumor antigen p53Homo sapiens (human)
disordered domain specific bindingCellular tumor antigen p53Homo sapiens (human)
general transcription initiation factor bindingCellular tumor antigen p53Homo sapiens (human)
molecular function activator activityCellular tumor antigen p53Homo sapiens (human)
promoter-specific chromatin bindingCellular tumor antigen p53Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (21)

Processvia Protein(s)Taxonomy
plasma membraneTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
stereocilium bundleTransient receptor potential cation channel subfamily A member 1Homo sapiens (human)
nuclear bodyCellular tumor antigen p53Homo sapiens (human)
nucleusCellular tumor antigen p53Homo sapiens (human)
nucleoplasmCellular tumor antigen p53Homo sapiens (human)
replication forkCellular tumor antigen p53Homo sapiens (human)
nucleolusCellular tumor antigen p53Homo sapiens (human)
cytoplasmCellular tumor antigen p53Homo sapiens (human)
mitochondrionCellular tumor antigen p53Homo sapiens (human)
mitochondrial matrixCellular tumor antigen p53Homo sapiens (human)
endoplasmic reticulumCellular tumor antigen p53Homo sapiens (human)
centrosomeCellular tumor antigen p53Homo sapiens (human)
cytosolCellular tumor antigen p53Homo sapiens (human)
nuclear matrixCellular tumor antigen p53Homo sapiens (human)
PML bodyCellular tumor antigen p53Homo sapiens (human)
transcription repressor complexCellular tumor antigen p53Homo sapiens (human)
site of double-strand breakCellular tumor antigen p53Homo sapiens (human)
germ cell nucleusCellular tumor antigen p53Homo sapiens (human)
chromatinCellular tumor antigen p53Homo sapiens (human)
transcription regulator complexCellular tumor antigen p53Homo sapiens (human)
protein-containing complexCellular tumor antigen p53Homo sapiens (human)
plasma membraneGlutamate receptor 2Rattus norvegicus (Norway rat)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (18)

Assay IDTitleYearJournalArticle
AID60994Growth inhibition of Don-6 cell lines at 1.0 mM concentration1981Journal of medicinal chemistry, Jun, Volume: 24, Issue:6
Synthesis and antitumor activity of cysteinyl-3,4-dihydroxyphenylalanines and related compounds.
AID134341Compound was tested for growth inhibition of YT-nu cell lines at 0.1 mM concentration1981Journal of medicinal chemistry, Jun, Volume: 24, Issue:6
Synthesis and antitumor activity of cysteinyl-3,4-dihydroxyphenylalanines and related compounds.
AID1254098Binding affinity to human PRDX5 expressed in Escherichia coli at ligand/protein ratio 120 measured over 0.5 to 4 secs by STD NMR spectrometric analysis2015Journal of medicinal chemistry, Nov-12, Volume: 58, Issue:21
Ligand-Orientation Based Fragment Selection in STD NMR Screening.
AID1070389Neuroprotective activity in mouse HT22 cells assessed as reduction of t-BOOH-induced oxidative stress at 40 uM preincubated for 3 hrs followed by t-BOOH induction measured for 20 hrs by time-resolved ECIS analysis2014Journal of natural products, Mar-28, Volume: 77, Issue:3
Flavonoids, flavonoid metabolites, and phenolic acids inhibit oxidative stress in the neuronal cell line HT-22 monitored by ECIS and MTT assay: a comparative study.
AID1682371Agonist activity at TRPA1 (unknown origin) by calcium imaging assay relative to allyl isothiocyanate2021Bioorganic & medicinal chemistry letters, 01-01, Volume: 31Discovery of natural TRPA1 activators through pharmacophore-based virtual screening and a biological assay.
AID1070383Neuroprotective activity in mouse HT22 cells assessed as t-BOOH-induced toxicity at 40 uM preincubated for 3 hrs followed by t-BOOH induction measured after 4.5 hrs by MTT assay2014Journal of natural products, Mar-28, Volume: 77, Issue:3
Flavonoids, flavonoid metabolites, and phenolic acids inhibit oxidative stress in the neuronal cell line HT-22 monitored by ECIS and MTT assay: a comparative study.
AID1186382Antimicrobial activity against Staphylococcus aureus ATCC 292132014Journal of natural products, Sep-26, Volume: 77, Issue:9
Antileishmanial metabolites from Geosmithia langdonii.
AID1186381Antimicrobial activity against methicillin-resistant Staphylococcus aureus ATCC 335912014Journal of natural products, Sep-26, Volume: 77, Issue:9
Antileishmanial metabolites from Geosmithia langdonii.
AID1059430Inhibition of recombinant human IDO1 expressed in Escherichia coli EC538 using L-tryptophan as substrate at 1 mM after 1 hr relative to control2013Bioorganic & medicinal chemistry, Dec-15, Volume: 21, Issue:24
Discovery and characterisation of hydrazines as inhibitors of the immune suppressive enzyme, indoleamine 2,3-dioxygenase 1 (IDO1).
AID134340Compound was tested for growth inhibition of Don-6 cell lines at 0.1 mM concentration1981Journal of medicinal chemistry, Jun, Volume: 24, Issue:6
Synthesis and antitumor activity of cysteinyl-3,4-dihydroxyphenylalanines and related compounds.
AID282835Cytotoxicity against mouse L1210 cells2005Journal of medicinal chemistry, Nov-17, Volume: 48, Issue:23
Cellular apoptosis and cytotoxicity of phenolic compounds: a quantitative structure-activity relationship study.
AID1070390Cytotoxicity against mouse HT22 cells assessed as cell viability at 40 uM after 24 hrs by MTT assay2014Journal of natural products, Mar-28, Volume: 77, Issue:3
Flavonoids, flavonoid metabolites, and phenolic acids inhibit oxidative stress in the neuronal cell line HT-22 monitored by ECIS and MTT assay: a comparative study.
AID1070384Neuroprotective activity in mouse HT22 cells assessed as t-BOOH-induced toxicity at 40 uM preincubated for 3 hrs followed by t-BOOH induction measured after 9 hrs by MTT assay2014Journal of natural products, Mar-28, Volume: 77, Issue:3
Flavonoids, flavonoid metabolites, and phenolic acids inhibit oxidative stress in the neuronal cell line HT-22 monitored by ECIS and MTT assay: a comparative study.
AID1070388Neuroprotective activity in mouse HT22 cells assessed as reduction of t-BOOH-induced oxidative stress at 40 uM preincubated for 3 hrs followed by t-BOOH induction measured after 20 hrs by MTT assay2014Journal of natural products, Mar-28, Volume: 77, Issue:3
Flavonoids, flavonoid metabolites, and phenolic acids inhibit oxidative stress in the neuronal cell line HT-22 monitored by ECIS and MTT assay: a comparative study.
AID1254101Binding affinity to human PRDX5 expressed in Escherichia coli at ligand/protein ratio 50 and 240 measured over 2 secs by STD NMR spectrometric analysis2015Journal of medicinal chemistry, Nov-12, Volume: 58, Issue:21
Ligand-Orientation Based Fragment Selection in STD NMR Screening.
AID1682372Agonist activity at TRPA1 (unknown origin) by calcium imaging assay2021Bioorganic & medicinal chemistry letters, 01-01, Volume: 31Discovery of natural TRPA1 activators through pharmacophore-based virtual screening and a biological assay.
AID220082Growth inhibition of YT-nu cell lines at 1.0 mM concentration1981Journal of medicinal chemistry, Jun, Volume: 24, Issue:6
Synthesis and antitumor activity of cysteinyl-3,4-dihydroxyphenylalanines and related compounds.
AID977611Experimentally measured binding affinity data (Kd) for protein-ligand complexes derived from PDB2014PloS one, , Volume: 9, Issue:7
Comparing binding modes of analogous fragments using NMR in fragment-based drug design: application to PRDX5.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (134)

TimeframeStudies, This Drug (%)All Drugs %
pre-19908 (5.97)18.7374
1990's33 (24.63)18.2507
2000's33 (24.63)29.6817
2010's46 (34.33)24.3611
2020's14 (10.45)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 39.79

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index39.79 (24.57)
Research Supply Index4.91 (2.92)
Research Growth Index5.05 (4.65)
Search Engine Demand Index55.56 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (39.79)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (0.75%)6.00%
Case Studies0 (0.00%)4.05%
Observational1 (0.75%)0.25%
Other132 (98.51%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]